Abstract
Gastrointestinal stromal tumors (GISTs) are defined as spindle cell and/or epithelioid tumors originated from interstitial Cajal cells or precursors in the digestive tract. This study was conducted to identify genes differing in expression between the gastric tumors and the adjacent non-cancerous mucosas in patients with primary gastric GIST. The gene expression profile was determined by using oligonucleotide-based DNA microarrays and further validated by quantitative real-time PCR. The Kyoto encyclopedia of genes and genomes (KEGG) pathway analysis was performed to predict signaling pathways involved in gastric GIST. Our data showed that the expression levels of 957 genes (RAB39B, member RAS oncogene family; VCAN, versican; etc.) were higher and that of 526 genes (CXCL14, chemokine C-X-C motif ligand 14; MTUS1, microtubule-associated tumor suppressor 1; etc.) were lower in the gastric tumor tissues as compared with normal gastric tissues. Results from KEGG pathway analysis revealed that the differentially expressed genes were enriched into 16 signaling transduction pathways, including Hedeghog and Wnt signaling pathways. Our study may provide basis for identification of novel biomarkers associated with primary gastric GIST pathogenesis and for exploration of underlying mechanisms involved in this gastric sarcoma.
Similar content being viewed by others
References
Miettinen, M., & Lasota, J. (2006). Gastrointestinal stromal tumors: Review on morphology, molecular pathology, prognosis, and differential diagnosis. Archives of Pathology and Laboratory Medicine, 2006(130), 1466–1478.
Hirota, S., Isozaki, K., Moriyama, Y., Hashimoto, K., Nishida, T., Ishiguro, S., et al. (1998). Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science, 1998(279), 577–580.
Vadakara, J., & von Mehren, M. (2013). Gastrointestinal stromal tumors: Management of metastatic disease and emerging therapies. Hematology/oncology Clinics of North America, 2013(27), 905–920.
Debiec-Rychter, M., Cools, J., Dumez, H., Sciot, R., Stul, M., Mentens, N., et al. (2005). Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants. Gastroenterology, 2005(128), 270–279.
Heller, M. J. (2002). DNA microarray technology: Devices, systems, and applications. Annual Review of Biomedical Engineering, 2002(4), 129–153.
Russo, G., Zegar, C., & Giordano, A. (2003). Advantages and limitations of microarray technology in human cancer. Oncogene, 2003(22), 6497–6507.
Mischel, P. S., Cloughesy, T. F., & Nelson, S. F. (2004). DNA-microarray analysis of brain cancer: Molecular classification for therapy. Nature Reviews Neuroscience, 2004(5), 782–792.
Terashima, M., Maesawa, C., Oyama, K., Ohtani, S., Akiyama, Y., Ogasawara, S., et al. (2005). Gene expression profiles in human gastric cancer: Expression of maspin correlates with lymph node metastasis. British Journal of Cancer, 2005(92), 1130–1136.
Milde-Langosch, K., Karn, T., Schmidt, M., zu Eulenburg, C., Oliveira-Ferrer, L., Wirtz, R. M., et al. (2014). Prognostic relevance of glycosylation-associated genes in breast cancer. Breast Cancer Research and Treatment, 2014(145), 295–305.
Koh, S. S., Opel, M. L., Wei, J. P., Yau, K., Shah, R., Gorre, M. E., et al. (2009). Molecular classification of melanomas and nevi using gene expression microarray signatures and formalin-fixed and paraffin-embedded tissue. Modern Pathology, 2009(22), 538–546.
Hur, K., Lee, H. J., Woo, J. H., Kim, J. H., & Yang, H. K. (2010). Gene expression profiling of human gastrointestinal stromal tumors according to its malignant potential. Digestive Diseases and Sciences, 2010(55), 2561–2567.
Setoguchi, T., Kikuchi, H., Yamamoto, M., Baba, M., Ohta, M., Kamiya, K., et al. (2011). Microarray analysis identifies versican and CD9 as potent prognostic markers in gastric gastrointestinal stromal tumors. Cancer Science, 2011(102), 883–889.
Liu, N., Liu, X., Zhou, N., Wu, Q., Zhou, L., & Li, Q. (2014). Gene expression profiling and bioinformatics analysis of gastric carcinoma. Experimental and Molecular Pathology, 2014(96), 361–366.
Arne, G., Kristiansson, E., Nerman, O., Kindblom, L. G., Ahlman, H., Nilsson, B., & Nilsson, O. (2011). Expression profiling of GIST: CD133 is associated with KIT exon 11 mutations, gastric location and poor prognosis. International Journal of Cancer, 2011(129), 1149–1161.
Yeung, K. Y., & Ruzzo, W. L. (2001). Principal component analysis for clustering gene expression data. Bioinformatics, 2001(17), 763–774.
Corless, C. L. (2014). Gastrointestinal stromal tumors: What do we know now? Modern Pathology, 7(Suppl 1), S1–16.
Corless, C. L., Barnett, C. M., & Heinrich, M. C. (2011). Gastrointestinal stromal tumours: Origin and molecular oncology. Nature Reviews Cancer, 2011(11), 865–878.
Yamaguchi, U., Nakayama, R., Honda, K., Ichikawa, H., Hasegawa, T., Shitashige, M., et al. (2008). Distinct gene expression-defined classes of gastrointestinal stromal tumor. Journal of Clinical Oncology, 2008(26), 4100–4108.
Godwin, A. K. (2011). Bench to bedside and back again: Personalizing treatment for patients with GIST. Molecular Cancer Therapeutics, 2011(10), 2026–2027.
Atay, S., Banskota, S., Crow, J., Sethi, G., Rink, L., & Godwin, A. K. (2014). Oncogenic KIT-containing exosomes increase gastrointestinal stromal tumor cell invasion. Proceedings of the National Academy of Sciences of the United States of America, 2014(111), 711–716.
Schmukler, E., Kloog, Y., & Pinkas-Kramarski, R. (2014). Ras and autophagy in cancer development and therapy. Oncotarget, 2014(5), 577–586.
Lin, Z., Zhang, C., Zhang, M., Xu, D., Fang, Y., Zhou, Z., et al. (2014). Targeting cadherin-17 inactivates Ras/Raf/MEK/ERK signaling and inhibits cell proliferation in gastric cancer. PLoS One, 2014(9), e85296.
Liu, Y., Wang, Z., Li, H., Wu, Z., Wei, F., & Wang, H. (2013). Role of the ERas gene in gastric cancer cells. Oncology Reports, 2013(30), 50–56.
Zhang, Z., Zhang, J., Miao, L., Liu, K., Yang, S., Pan, C., & Jiao, B. (2012). Interleukin-11 promotes the progress of gastric carcinoma via abnormally expressed versican. International Journal of Biological Sciences, 2012(8), 383–393.
Miyake, M., Lawton, A., Goodison, S., Urquidi, V., & Rosser, C. J. (2014). Chemokine (C-X-C motif) ligand 1 (CXCL1) protein expression is increased in high-grade prostate cancer. Pathology, Research and Practice, 2014(210), 74–78.
Hsu, Y. L., Hou, M. F., Kuo, P. L., Huang, Y. F., & Tsai, E. M. (2013). Breast tumor-associated osteoblast-derived CXCL5 increases cancer progression by ERK/MSK1/Elk-1/snail signaling pathway. Oncogene, 2013(32), 4436–4447.
Kee, J. Y., Ito, A., Hojo, S., Hashimoto, I., Igarashi, Y., Tsukada, K., et al. (2013). Chemokine CXCL16 suppresses liver metastasis of colorectal cancer via augmentation of tumor-infiltrating natural killer T cells in a murine model. Oncology Reports, 2013(29), 975–982.
Wang, W., Huang, P., Zhang, L., Wei, J., Xie, Q., Sun, Q., et al. (2013). Antitumor efficacy of C-X-C motif chemokine ligand 14 in hepatocellular carcinoma in vitro and in vivo. Cancer Science, 2013(104), 1523–1531.
Hu, C., Lin, F., Zhu, G., Xue, X., Ding, Y., Zhao, Z., et al. (2013). Abnormal hypermethylation of promoter region downregulates chemokine CXC ligand 14 expression in gastric cancer. International Journal of Oncology, 2013(43), 1487–1494.
Li, X., Liu, H., Yu, T., Dong, Z., Tang, L., & Sun, X. (2014). Loss of MTUS1 in gastric cancer promotes tumor growth and metastasis. Neoplasma, 2014(61), 128–135.
Pelczar, P., Zibat, A., van Dop, W. A., Heijmans, J., Bleckmann, A., Gruber, W., et al. (2013). Inactivation of Patched1 in mice leads to development of gastrointestinal stromal-like tumors that express Pdgfralpha but not kit. Gastroenterology, 144, 134–144 e6.
Oshima, H., Oguma, K., Du, Y. C., & Oshima, M. (2009). Prostaglandin E2, Wnt, and BMP in gastric tumor mouse models. Cancer Science, 2009(100), 1779–1785.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kou, Y., Zhao, Y., Bao, C. et al. Comparison of Gene Expression Profile Between Tumor Tissue and Adjacent Non-tumor Tissue in Patients with Gastric Gastrointestinal Stromal Tumor (GIST). Cell Biochem Biophys 72, 571–578 (2015). https://doi.org/10.1007/s12013-014-0504-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12013-014-0504-5